2019 Symposium
|
2013 Featured Talks » Carfilzomib: Investigation in Small Cell Lung Cancer (SCLC)Carfilzomib: Investigation in Small Cell Lung Cancer (SCLC)Paula O'Connor, MD, Onyx Pharmaceuticals » Download Audio Paula O'Connor, MD, is a board eligible hematologist oncologist with 10 years of industry experience. She currently serves as Senior Medical Director at Onyx Pharmaceuticals, working on Nexavar, Carfilzomib and other pipeline agents. As a clinical science lead, her responsibilities have included protocol development and medical management for registration trials, interpretation of Phase II and III trial data, and interacting with the FDA. Her most recent responsibility is the development of a clinical program for Carfilzomib in Small Cell Lung Cancer.
|